Journal
/
Inmunología y contagio
/
Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
JoVE Revista
Inmunología y contagio
Se requiere una suscripción a JoVE para ver este contenido.  Inicie sesión o comience su prueba gratuita.
JoVE Revista Inmunología y contagio
Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

DOI:
10.3791/59920-v

•

06:03 min

•

July 15, 2019

•

, , ,
1Department of Molecular Biosciences,University of Texas at Austin, 2School of Pharmacy, College of Pharmacy,Kaohsiung Medical University, 3Graduate Institute of Medical Sciences, College of Medicine,Taipei Medical University, 4Department of Microbiology and Immunology,Dalhousie University, 5Department of Microbiology and Immunology, School of Medicine, College of Medicine,Taipei Medical University

Capítulos

  • 00:04Título
  • 00:27Time-of-Drug-Addition
  • 02:25Molecular Docking Analysis
  • 04:06Results: Representative Effects of Small Molecule (CHLA and PUG) Binding Against CVA16 Infectivity
  • 05:33Conclusion

Summary

Traducción Automática

Traducción Automática

The goal of the protocol is to illustrate the different assays relating to viral entry that can be used to identify candidate viral entry inhibitors.

Tags

Viral Entry AssayMolecular DockingAntiviral CandidatesCoxsackievirus A16RD CellsPlaque-forming UnitsMethylcelluloseCrystal VioletPubChemProtein Data BankMolecular ProgramBio-computing Program

Article

Embed

Añadir a la lista de reproducción

Usage Statistics

Videos relacionados

The Use of Drip Flow and Rotating Disk Reactors for Staphylococcus aureus Biofilm Analysis

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii

Swab Sampling Method for the Detection of Human Norovirus on Surfaces

Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins

Read Article